Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Amiodarone
Drug ID BADD_D00115
Description Amiodarone is a benzofuran derivative, anti-arrhythmic drug used commonly in a variety of settings.[A36817] Most known for its approved indication in life-threatening ventricular arrhythmias, it is also used off-label in the outpatient and inpatient setting for atrial fibrillation. Because of its ability to cause serious toxicity and possibly death, amiodarone use should be reserved for its approved indications, according to prescribing information.[L3561,L11265,L11286]
Indications and Usage Intravenously, for initiation of treatment and prophylaxis of frequently recurring ventricular fibrillation and hemodynamically unstable ventricular tachycardia in patients refractory to other therapy. Orally, for the treatment of life-threatening recurrent ventricular arrhythmias such as recurrent ventricular fibrillation and recurrent hemodynamically unstable ventricular tachycardia.
Marketing Status Prescription; Discontinued
ATC Code C01BD01
DrugBank ID DB01118
KEGG ID D02910
MeSH ID D000638
PubChem ID 2157
TTD Drug ID D0L5WM
NDC Product Code Not Available
Synonyms Amiodarone | Amiodarona | Amiodarone Hydrochloride | Hydrochloride, Amiodarone | Amiohexal | Aratac | Tachydaron | Corbionax | Cordarone | Amiodarex | Trangorex | Kordaron | Cordarex | L-3428 | L 3428 | L3428 | Ortacrone | Rytmarone | SKF 33134-A | SKF 33134 A | SKF 33134A | Amiobeta | Braxan
Chemical Information
Molecular Formula C25H29I2NO3
CAS Registry Number 1951-25-3
SMILES CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCCN(CC)CC)I
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
HaemorrhageCytochrome P450 2C9P11712T19244806430; 5458032; 1109248
HypotensionCytochrome P450 3A4P08684T378488805725; 8805726; 7489857; 8614120
Liver injuryAlanine aminotransferase 1Q8QZR5Not Available25900201
Poisoning and toxicityCytochrome P450 2D6P10635T57392Not Available
RhabdomyolysisCytochrome P450 3A4P08684T378488805725; 8805726; 7489857; 8614120
Sudden cardiac deathPotassium voltage-gated channel subfamily KQT member 1P51787T495269927398; 10810773; 10082151; 10408028
Sudden cardiac deathSodium channel protein type 5 subunit alphaQ14524T397169927398; 10810773; 10082151; 10408028
Sudden cardiac deathPotassium voltage-gated channel subfamily E member 1P15382Not Available9927398; 10810773; 10082151; 10408028
Sudden cardiac deathPotassium voltage-gated channel subfamily H member 2Q12809T202519927398; 10810773; 10082151; 10408028
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Tachyarrhythmia02.03.02.0080.001191%Not Available
Abasia17.02.05.035; 08.01.02.0070.004464%Not Available
Balance disorder17.02.02.0070.001488%Not Available
Dysstasia17.02.02.0120.000595%Not Available
Electrocardiogram T wave abnormal13.14.05.0090.000893%
Ejection fraction decreased13.14.02.0030.001786%
Lupus-like syndrome15.06.02.004; 10.04.03.003; 23.03.02.0040.000595%Not Available
Contusion12.01.06.001; 24.07.06.001; 23.03.11.002; 15.03.01.0080.002083%
Foreign body sensation in eyes06.01.01.006--Not Available
Exercise tolerance decreased08.01.03.0360.000893%Not Available
Acute coronary syndrome24.04.04.011; 02.02.02.0150.002083%Not Available
Lymphoid tissue hyperplasia01.09.01.0090.003869%Not Available
Haemodynamic instability24.03.02.0060.001191%Not Available
Ocular discomfort06.08.03.008--Not Available
Foetor hepaticus07.01.06.026; 09.01.05.006--Not Available
Eosinophilic pneumonia acute22.01.01.008; 01.02.04.0040.000595%Not Available
Inappropriate antidiuretic hormone secretion14.05.07.001; 05.03.03.001--Not Available
Transaminases increased13.03.01.015--Not Available
Haemorrhage24.07.01.0020.004762%Not Available
Pulmonary mass22.02.07.0040.000893%Not Available
Congestive cardiomyopathy02.04.01.0030.000893%Not Available
Peripheral sensorimotor neuropathy17.09.03.009--Not Available
Temperature intolerance08.01.09.0220.000595%Not Available
QRS axis abnormal13.14.05.0260.000595%Not Available
Cognitive disorder19.21.02.001; 17.03.03.003--
Toxic skin eruption23.03.05.003; 10.01.01.0080.000893%Not Available
Pulseless electrical activity02.03.04.020--Not Available
Thyroid mass05.02.01.003--Not Available
Disturbance in sexual arousal19.08.04.003--Not Available
Brugada syndrome02.03.01.0130.001191%Not Available
The 14th Page    First    Pre   14 15 16 17    Next   Last    Total 17 Pages